Spencer Laird, a working father from South Carolina, is actively participating in a colorectal cancer immunotherapy clinical trial led by Dr. DeVito at Duke University and he’s responding well to treatment. Dr. DeVito’s research explores a new approach to colorectal cancer care that uses immunotherapy alone, without chemotherapy. For younger patients like Spencer, avoiding the side effects commonly associated with chemo has made a meaningful difference, allowing him to stay active, continue working, and remain present for his wife, CarleyAnn, and other family members while undergoing treatment. Spencer's medical journey has deepened his faith which he attributes to supporting his healing. While this research is still ongoing, Spencer’s experience offers insight into how immunotherapy-only approaches may change cancer care for certain patients in the future. Each clinical trial brings researchers one step closer to more personalized, patient-centered treatment options. 𝐀𝐛𝐨𝐮𝐭 𝐃�...